Fractionated administration of irinotecan and cisplatin in Japanese patients with extensive-stage-disease small-cell lung cancer [7]

Journal of Clinical Oncology

Volumn 24, Issue 32, 2006, Pages 5175-

  Takigawa, Nagio ^a   Kiura, Katsuyuki ^a   Tabata, Masahiro ^a   Tanimoto, Mitsune ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN; ANTINEOPLASTIC AGENT; CAMPTOTHECIN; DRUG DERIVATIVE;

CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; COLORECTAL CANCER; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; DRUG DOSE ESCALATION; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; HUMAN; JAPANESE; LETTER; LUNG SMALL CELL CANCER; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; TOXICITY; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; DOSE RESPONSE; JAPAN; LUNG TUMOR; MORTALITY; NOTE; PATHOLOGY; SALVAGE THERAPY; SAMPLE SIZE; SMALL CELL CARCINOMA; TIME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAMPTOTHECIN; CARCINOMA, SMALL CELL; CISPLATIN; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; JAPAN; LUNG NEOPLASMS; SALVAGE THERAPY; SAMPLE SIZE; TIME FACTORS;

EID: 34247209086     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2006.07.5531     Document Type: Letter

References (5)

1. Hanna N, Bunn PA Jr, Langer C, et al: Randomized phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancer. J Clin Oncol 24:2038-2043, 2006
2. Noda K, Nishiwaki Y, Kawahara M, et al: Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer. N Engl J Med 346:85-91, 2002
3. Ueoka H, Tabata M, Kiura K, et al: Fractionated administration of irinotecan and cisplatin for treatment of lung cancer: A phase I study. Br J Cancer 79:984-990, 1999
4. Takigawa N, Fujiwara K, Ueoka H, et al: Fractionated administration of irinotecan and cisplatin for treatment of extensive-disease small-cell lung cancer: A phase II study. Anticancer Res 23:557-560, 2003
5. Tournigand C, Andre T, Achille E, et al: FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: A randomized GERCOR study. J Clin Oncol 22:229-237, 2004